Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Gut Microbiota Reconstruction for NSCLC Immunotherapy
- Status
- UNKNOWN
- Phase
- PHASE1
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
AB122 Platform Study
- Status
- RECRUITING
- Phase
- PHASE1
Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
PD-L1 Expression in Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression
- Status
- UNKNOWN
- Phase
- PHASE2
Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2